Ron H.J. Mathijssen

Researcher Next ID · RN-033680

Researcher · Biochemistry, Genetics and Molecular Biology

Rotterdam, Netherlands

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Cancer Treatment and Pharmacology

Lung Cancer Treatments and Mutations

Prostate Cancer Treatment and Research

Cancer therapeutics and mechanisms

Colorectal Cancer Treatments and Studies

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30686-7
Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(13)70579-5
Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
British Journal of Cancer · 2013 · https://doi.org/10.1038/bjc.2013.48
Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity
Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2008.21.7679
Evaluation of Alternate Size Descriptors for Dose Calculation of Anticancer Drugs in the Obese
Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2007.11.2938
Irinotecan pathway genotype analysis to predict pharmacokinetics.
PubMed · 2003

No projects listed.